ERAS vs ILMN · $4.13B cap vs rev $2.25B
Erasca Inc (ERAS) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Erasca Inc (ERAS) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
ERAS does not have a complete income-statement cache yet.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
ERAS currently screens at market cap $4.13B. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the ERAS and ILMN stock pages for the full models.
Not investment advice.